Aneta Bąk

ORCID: 0000-0001-8879-2521
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac, Anesthesia and Surgical Outcomes
  • Aortic aneurysm repair treatments
  • Connective tissue disorders research
  • BRCA gene mutations in cancer
  • Neuropeptides and Animal Physiology
  • Dermatological and Skeletal Disorders
  • Acute Myeloid Leukemia Research
  • Genetic factors in colorectal cancer
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Vascular Procedures and Complications
  • Prostate Cancer Treatment and Research
  • Plant Pathogens and Resistance
  • Chronic Myeloid Leukemia Treatments
  • Birth, Development, and Health
  • PI3K/AKT/mTOR signaling in cancer
  • Menopause: Health Impacts and Treatments
  • Heart Rate Variability and Autonomic Control
  • Wnt/β-catenin signaling in development and cancer
  • Drug Transport and Resistance Mechanisms
  • Cardiovascular and exercise physiology
  • Glutathione Transferases and Polymorphisms
  • Breast Cancer Treatment Studies
  • Cancer Risks and Factors
  • Blood Pressure and Hypertension Studies
  • Colorectal Cancer Screening and Detection

Nicolaus Copernicus University
2011-2023

Collegium Medicum in Bydgoszcz
2015-2023

University of British Columbia
2020-2023

Kelowna General Hospital
2022-2023

Catharina Ziekenhuis
2016

Radboud University Nijmegen
2016

Bureau Waardenburg (Netherlands)
2005

Utrecht University
2005

University Medical Center Utrecht
2000-2002

Schools of Visual Arts, The Royal Danish Academy of Fine Arts
1998-1999

Theodorus G. van Schaik Kak Khee Yeung Hence J.M. Verhagen Jorg L. de Bruin Marc R.H.M. van Sambeek and 94 more Ron Balm Clark J. Zeebregts Joost A. van Herwaarden Jan D. Blankensteijn Diederick E. Grobbee Jan D. Blankensteijn Aneta Bąk Jacob Buth Peter M. T. Pattynama Eric Verhoeven A E van Voorthuisen Jan D. Blankensteijn Ron Balm Jacob Buth Philippe W.M. Cuypers Diederick E. Grobbee Monique Prinssen Marc R.H.M. van Sambeek Eric Verhoeven Annette F. Baas M. G. Myriam Hunink J.M. van Engelshoven M.J. Jacobs Bas A.J.M. de Mol J. Hajo van Bockel Ron Balm J.A. Reekers Xander Tielbeek Eric Verhoeven Willem Wisselink N. Boekema L.M. Heuveling I. Sikking Monique Prinssen Ron Balm Jan D. Blankensteijn Jacob Buth Philippe W.M. Cuypers Marc R.H.M. van Sambeek Eric Verhoeven Jorg L. de Bruin Annette F. Baas Jan D. Blankensteijn Monique Prinssen Jacob Buth Alexander V. Tielbeek Jan D. Blankensteijn Ron Balm J.A. Reekers Marc R.H.M. van Sambeek Peter M. T. Pattynama Eric Verhoeven T.R. Prins Arie C. van der Ham J.J.I.M. van der Velden Steven M.M. van Sterkenburg G.B. ten Haken C.M.A. Bruijninckx Hans van Overhagen R.P. Tutein Nolthenius Tadek R. Hendriksz Joep A.W. Teijink Henk F. Odink A.A.E.A. de Smet Dammis Vroegindeweij R.M.M. van Loenhout Matthieu Rutten J.F. Hamming L. E. H. Lampmann M.H. Bender H. Pasmans A.C. Vahl C de Vries A. J. C. Mackaay L.M.C. van Dortmont A.J. van der Vliet Leo J. Schultze Kool J.H.B. Boomsma H.R. van Dop J.C.A. de Mol van Otterloo T.P.W. de Rooij T.M. Smits Emre Yılmaz Willem Wisselink F.G. van den Berg M.J. Visser Edwin van der Linden Geert Willem H. Schurink Mariëtte de Haan H.J. Smeets P. Stabel F. Van Elst J Poniewierski Frank Vermassen

Randomized trials have shown an initial survival benefit of endovascular over conventional open abdominal aortic aneurysm repair but no long-term difference up to 6 years after repair. Longer follow-up may be required demonstrate the cumulative negative impact on higher reintervention rates associated with repair.We updated results Dutch Endovascular Aneurysm Management (DREAM) trial, a multicenter, randomized controlled trial comparing repair, 15 follow-up. Survival and reinterventions were...

10.1016/j.jvs.2017.05.122 article EN cc-by-nc-nd Journal of Vascular Surgery 2017-10-20

<h3>Abstract</h3> <b>Objective</b> : To examine the effect of a reduced sodium and increased potassium magnesium intake on blood pressure. <b>Design</b> Randomised double blind placebo controlled trial. <b>Setting</b> General population suburb Rotterdam. <b>Subjects</b> 100 men women between 55 75 years age with untreated mild to moderate hypertension. <b>Interventions</b> During 24 weeks intervention group received mineral salt (sodium: potassium: 8:6:1) foods prepared salt. Controls common...

10.1136/bmj.309.6952.436 article EN BMJ 1994-08-13
Stephanie L. Harrison Deirdre A. Lane Maciej Banach Mirosław Mastej Sławomir Kasperczyk and 95 more Jacek Jerzy Jozwiak Gregory Y.H. Lip B. Al-Shaer W. Andrusewicz M. Andrzejczuk-Rosa E. Anusz-Gaszewska Anna Baginska P. Balawajder Gaurav Banka E. Barańska-Skubisz B. Barbara Przyczyna S. Bartkowiak J. Bartodziej Małgorzata Bartosiewicz M. Basałyga A. Batyra Aneta Bąk Mark S. Bednarz K. Bejnar W. Bernacki M. Betiuk-Kwiatkowska S. Biegaj Marta Bień W. Bilski M. Biłogan G. Biruta-Pawłowska A. Biskup Barbara Błaszczyk H. Błaszczyk T. Błońska-Jankowska B. Bogacka-Gancarczyk Marzena Bojanowska Elżbieta Bonda-Ostaszewska J. Borowik-Skwarek J. Borowska James V. Bruckner Jerzy Brzostek M. Brzuchacz M. Budzyńska I. Bulzacka-Fugiel J. Bulzak K. Bunikowski A. Cebulska T. Celka E. Cempel-Nowak W. Chechliński A. Chludzińska D. Chmiel Magdalena Chmielewska M. Cichy A. Ciemięga A. Ciepluch I. Cieszyńska Beata Czajka B. Czapla M. Czerner Barbara Czerwińska W. Czuryszkiewicz E. Daleka Z. Dawid Magdalena Dąbrowska Renata Dąbrowska D. Dąbrowski Maciej Dąbrowski K. Demczyszyn A. Dębowska-Serwińska Jacek Dmochowski J. Dobrzecka-Kiwior E. Dolanowska H. Dolanowski P. Dołek Michał Domagała Henryk A. Domanski A. Doszel D. Duda Magdalena Dudkowska B. Dudziuk P. Dybciak M. Dymanowski L. Dziadzio-Bolek M. Eicke H. El-Hassan A. Eremus M. Fąferek-Muller E. Figura-Roguska I. Fijałkowska-Kaczmarek Marta Flis T. Florczak Mateusz Florczuk E. Foryszewska-Witan W. Frydrych A. Fugiel E. Futyma A. Gaca-Jaroszewicz I. Gajdamowicz

10.1016/j.atherosclerosis.2020.08.026 article EN Atherosclerosis 2020-09-06
Jorg L. de Bruin Rolf H. H. Groenwold Annette F. Baas Jack Brownrigg Monique Prinssen and 92 more D. E. Grobbee Jan D. Blankensteijn Diederick E. Grobbee Jan D. Blankensteijn Aneta Bąk Jacob Buth Peter M. T. Pattynama Eric L.G. Verhoeven A E van Voorthuisen Jan D. Blankensteijn Ron Balm Jacob Buth Ph. Cuypers Diederick E. Grobbee Monique Prinssen Marc R.H.M. van Sambeek Eric L.G. Verhoeven Annette F. Baas M. G. Myriam Hunink J M van Engelshoven Michael J. Jacobs Bas A.J.M. de Mol J. Hajo van Bockel Ron Balm J.A. Reekers Xander Tielbeek Eric L.G. Verhoeven Willem Wisselink N. Boekema L. Sikking Monique Prinssen Ron Balm Jan D. Blankensteijn Jacob Buth Ph. Cuypers Marc R.H.M. van Sambeek Eric L.G. Verhoeven Jorg L. de Bruin Annette F. Baas Jan D. Blankensteijn Monique Prinssen Erik Buskens Jacob Buth Alexander V. Tielbeek Jan D. Blankensteijn Ron Balm Jim A. Reekers Marc R.H.M. van Sambeek Peter M. T. Pattynama Eric L.G. Verhoeven Taco Jan Prins Arie C. van der Ham J.J.I.M. van der Velden Steven M.M. van Sterkenburg G.B. ten Haken C.M.A. Bruijninckx Hans van Overhagen R.P. Tutein Nolthenius Tadek R. Hendriksz Joep A.W. Teijink Henk F. Odink A.A.E.A. de Smet Dammis Vroegindeweij R.M.M. van Loenhout Matthieu Rutten Jaap F. Hamming L. E. H. Lampmann M.H. Bender Hella Pasmans A.C. Vahl C de Vries A. J. C. Mackaay L.M.C. van Dortmont A.J. van der Vliet Leo J. Schultze Kool J.H.B. Boomsma H.R. van Dop J.C.A. de Mol van Otterloo T.P.W. de Rooij T.M. Smits Ercüment Yılmaz Willem Wisselink F G van den Berg Vrije Michel J.T. Visser E van der Linden Geert Willem H. Schurink Mariëtte de Haan H.J. Smeets P. Stabel F. Van Elst J Poniewierski Frank Vermassen

Long-term survival is similar after open or endovascular repair of abdominal aortic aneurysm. Few data exist on the effect either procedure long-term health-related quality life (HRQoL) and health status.Patients enrolled in a multicentre randomized clinical trial (DREAM trial; 2000-2003) Europe versus (EVAR) aneurysm were asked to complete questionnaires status HRQoL. HRQoL scores assessed at baseline 13 time points thereafter, using generic tools, Medical Outcomes Study 36-Item Short-Form...

10.1002/bjs.10130 article EN British journal of surgery 2016-04-05

Collagen, the most abundant human protein, is a significant component of extracellular matrix (ECM) in tissues and organs like skin, bone, ligaments, tendons. Collagen secretion complex, multistage process involving many molecules. A protein playing one main functions this TANGO1 encoded by MIA3 gene. In hypermobile type Ehlers-Danlos syndrome (hEDS), common collagenopathies with no known genetic background, disrupted molecules (including collagen) was observed.The aim study evaluation gene...

10.17219/acem/158028 article EN cc-by Advances in Clinical and Experimental Medicine 2023-01-05

Germline mutations of the CHEK2 gene have been reported in some myeloid and lymphoid malignancies, but their impact on development essential thrombocythemia has not studied. In 16 out 106 (15.1%) consecutive patients, newly diagnosed with thrombocythemia, we found one four analyzed mutations: I157T, 1100delC, IVS2+1G>A or del5395. They were associated increased risk disease (OR=3.8; P=0.002). The median age at ET diagnosis among CHEK2+/JAK2V617F+ patients was seven years lower than that...

10.3324/haematol.2011.049494 article EN cc-by-nc Haematologica 2011-11-04

Germline mutations of the CHEK2 gene have been reported to be associated with breast cancer. In this study, we analyzed association risk development cancer in women North-Central Poland.420 and 435 controls were tested for three protein truncating (IVS2 + 1G > A, 1100delC, del5395) one missense (I157T) mutation. IVS2 A I157T identified by RFLP-PCR, 1100delC variant was using an ASO-PCR del5395 mutation multiplex-PCR. The statistical tests: odds ratio (OR) Fisher's exact test used.In 33 out...

10.1186/1897-4287-12-10 article EN cc-by Hereditary Cancer in Clinical Practice 2014-04-08

Abstract: In an earlier study using Caco‐2 cells, in vitro cell culture model of the intestinal mucosa, we have shown that acyloxyalkoxy‐based cyclic prodrugs 3 and 4 opioid peptides [Leu 5 ]‐enkephalin( 1 , H‐Tyr‐GLY‐Gly‐Phe‐Leu‐OH) DADLE( 2 H‐Tyr‐ d ‐Ala‐Gly‐Phe‐ ‐Leu‐OH), respectively, were substrates for apically polarized efflux systems therefore less able to permeate monolayers than themselves. attempt explain how structure may influence recognition these as by systems, determined...

10.1034/j.1399-3011.1999.00077.x article EN Journal of Peptide Research 1999-04-01

Abstract: The objective of this work was to synthesize the cyclic prodrugs 1 and 2 [Leu 5 ]‐enkephalin (Tyr‐Gly‐Gly‐Phe‐Leu‐OH) DADLE (Tyr‐D‐Ala‐Gly‐Phe‐D‐Leu‐OH), respectively, using an (acyloxy)alkoxy linker. were synthesized via a convergent method promoiety that connected C ‐ N ‐terminus peptides. key intermediates compounds 6a 9a for prodrug 6b 9b . (or ) coupled give compound 10a 10b ). protecting groups removed from 11a 11b, which then treated with HBTU in 40% 53% yields,...

10.1034/j.1399-3011.1999.00070.x article EN Journal of Peptide Research 1999-04-01

The Ehlers-Danlos syndrome (EDS) is a non-inflammatory, heritable connective tissue disorder divided into 13 types according to the 2017 International Classification of syndromes. One subtypes EDS, classical (cEDS), characterized by joint hypermobility, skin hyperextensibility and atrophic scars, which are major criteria cEDS.In this study, first in Central Eastern Europe, 44 patients were investigated. All them tested for COL5A1 mutations with direct DNA sequencing.The study group included...

10.5114/ada.2018.79440 article EN Advances in Dermatology and Allergology 2019-01-01
Paweł Krzemień Sławomir Kasperczyk Maciej Banach Aleksandra Kasperczyk Michał Dobrakowski and 95 more Tomasz Tomasik Adam Windak Mirosław Mastej Alberico L. Catapano Kausik K. Ray Dimitri P. Mikhailidis Peter P. Tóth George Howard Gregory Y.H. Lip Maciej Tomaszewski Fadi J. Charchar Naveed Sattar Bryan Williams Thomas M. MacDonald Peter E. Penson Jacek Jerzy Jozwiak B. Al-Shaer W. Andrusewicz M. Andrzejczuk-Rosa E. Anusz-Gaszewska Anna Baginska P. Balawajder Gaurav Banka E. Barańska-Skubisz B. Barbara Przyczyna S. Bartkowiak J. Bartodziej Małgorzata Bartosiewicz M. Basałyga A. Batyra Aneta Bąk Mark S. Bednarz K. Bejnar W. Bernacki M. Betiuk-Kwiatkowska S. Biegaj Marta Bień W. Bilski M. Biłogan G. Biruta-Pawłowska A. Biskup Barbara Błaszczyk H. Błaszczyk T. Błońska-Jankowska B. Bogacka-Gancarczyk Marzena Bojanowska Elżbieta Bonda-Ostaszewska J. Borowik-Skwarek J. Borowska James V. Bruckner Jerzy Brzostek M. Brzuchacz M. Budzyńska I. Bulzacka-Fugiel J. Bulzak K. Bunikowski A. Cebulska T. Celka E. Cempel-Nowak W. Chechliński A. Chludzińska D. Chmiel Magdalena Chmielewska M. Cichy A. Ciemięga A. Ciepluch I. Cieszyńska Beata Czajka B. Czapla M. Czerner Barbara Czerwińska W. Czuryszkiewicz E. Daleka Z. Dawid Magdalena Dąbrowska Renata Dąbrowska D. Dąbrowski Maciej Dąbrowski K. Demczyszyn A. Dębowska-Serwińska Jacek Dmochowski J. Dobrzecka-Kiwior E. Dolanowska H. Dolanowski P. Dołek Michał Domagała Henryk A. Domanski A. Doszel D. Duda Magdalena Dudkowska B. Dudziuk P. Dybciak M. Dymanowski L. Dziadzio-Bolek M. Eicke

The detection of antinuclear autoantibody (ANA) is dependent on many factors and varies between the populations. aim study was first to assess prevalence ANA in Polish adult population depending age, sex cutoff threshold used for results obtained. Second, we estimated occurrence individual types ANA-staining patterns. We tested 1731 patient samples using commercially available IIFA two thresholds 1:100 1:160. found 260 participants (15.0%), but percentage positive strongly depended level....

10.1007/s00296-021-05033-9 article EN cc-by Rheumatology International 2021-11-10
Jorg L. de Bruin Alan Karthikesalingam Peter Holt Monique Prinssen Matt Thompson and 91 more Jan D. Blankensteijn D. E. Grobbee Jan D. Blankensteijn Aneta Bąk Jacob Buth Peter M. T. Pattynama Eric L.G. Verhoeven A E van Voorthuisen Jan D. Blankensteijn Ron Balm Jacob Buth Philippe W.M. Cuypers D. E. Grobbee Monique Prinssen Marc R.H.M. van Sambeek Eric L.G. Verhoeven Annette F. Baas M. G. Myriam Hunink J.M. van Engelshoven M.J. Jacobs Bas A.J.M. de Mol J. Hajo van Bockel Ron Balm J.A. Reekers Xander Tielbeek Eric L.G. Verhoeven Willem Wisselink N. Boekema L.M. Heuveling I. Sikking Monique Prinssen Ron Balm Jan D. Blankensteijn Jacob Buth Philippe W.M. Cuypers Marc R.H.M. van Sambeek Eric L.G. Verhoeven Jorg L. de Bruin Annette F. Baas Jan D. Blankensteijn Monique Prinssen Jacob Buth Alexander V. Tielbeek Jan D. Blankensteijn Ron Balm J.A. Reekers Marc R.H.M. van Sambeek Peter M. T. Pattynama Eric L.G. Verhoeven T.R. Prins Arie C. van der Ham J.J.I.M. van der Velden Steven M.M. van Sterkenburg G.B. ten Haken C.M.A. Bruijninckx Hans van Overhagen R.P. Tutein Nolthenius Tadek R. Hendriksz Joep A.W. Teijink Henk F. Odink A.A.E.A. de Smet Dammis Vroegindeweij R.M.M. van Loenhout Matthieu Rutten Jaap F. Hamming L. E. H. Lampmann M.H. Bender H. Pasmans A.C. Vahl C de Vries A. J. C. Mackaay L.M.C. van Dortmont A.J. van der Vliet Leo J. Schultze Kool J.H.B. Boomsma H.R. van J.C.A. de Mol van Otterloo T.P.W. de Rooij T.M. Smits Emre Yılmaz Willem Wisselink F.G. van den Berg Michel J.T. Visser Edwin van der Linden Geert Willem H. Schurink Mariëtte de Haan H.J. Smeets P. Stabel F. Van Elst J Poniewierski Frank Vermassen

10.1016/j.jvs.2015.12.028 article EN publisher-specific-oa Journal of Vascular Surgery 2016-03-19

We tested the association between HOXB13 G84E (rs138213197) germline mutation and PC risk in Polish men. DNA from 103 consecutive, newly diagnosed patients hospitalised because of men: volunteers, healthy at time study. The was genotyped using Sanger sequencing. detected 2.9% men (3/103) not any man. Two carriers originated two 25 families fulfilling hereditary prostate cancer criteria (HPC) one carrier family among 78 without HPC (PC frequency: 8% vs. 1.3%, OR = 6.70, p 0.13). In three...

10.5114/pjp.2019.87103 article EN cc-by-nc-sa Polish Journal of Pathology 2019-01-01

The frameshift NOD2 gene mutation 3020insC is predominantly associated with Crohn's disease, but predisposes to many types of common cancers as well. We studied the frequency this mutant allele in 148 breast cancer women from Bydgoszcz region Poland. was present 8.8% patients. mean age at diagnosis carriers 43 years. did not find any patients diagnosed after 50 There no association a strong family history cancer. On contrary, (11.4%) two times higher families single case and aggregation...

10.1186/1897-4287-4-1-15 article EN cc-by Hereditary Cancer in Clinical Practice 2006-01-15

A small but important proportion of patients (4-10 %) with AML have germline mutations. They can cause the development at an earlier age, confer a higher risk relapse or predispose to secondary leukemias, including therapy-related leukemias. The analysis mutations in patient and his/her family is also critical for selection suitable donors if candidate hematopoietic stem cell transplantation (HSCT). 103 unrelated consecutive de novo were enrolled study. Control group consisted persons from...

10.1186/s13053-021-00200-2 article EN cc-by Hereditary Cancer in Clinical Practice 2021-10-12
Coming Soon ...